OX1R antagonists also have an advantage over SSRIs which become effective 2–3 weeks after daily use (Pollack et al., 2007a,b) and tend to increase anxiety symptoms initially both clinically (Goddard et al., 2001) and preclinically (Ravinder et al., 2013). The gene discussed is HCRTR1; the disease is Anxiety.